Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.005Source: DataRank Database

Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival is a research paper published in Gynecologic Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (15)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Lauren Cobb ORCID,Shannon N. Westin ORCID,Yingao Zhang ORCID,Amir A. Jazaeri ORCID,Anaís Malpica

Live enrichment

PubMed:36137845 PMC:PMC12073492

National Cancer Institute

Grant: P30 CA016672

National Cancer Institute

Grant: CA 217685

NCI NIH HHS

Grant: P50 CA217685

University of Texas MD Anderson Cancer Center

National Institutes of Health

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12073492

publisherhttps://api.elsevier.com/content/article/PII:S0090825822005911?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0090825822005911?httpAccept=text/plain

MeSH Terms

PeritoneumHumansCystadenocarcinoma, SerousOvarian NeoplasmsNeoplasm Recurrence, LocalAromatase InhibitorsDisease-Free SurvivalRetrospective StudiesFemaleCarcinoma, Ovarian Epithelial

Keywords

OvaryPeritoneumChemotherapyAromatase InhibitorLow-grade Serous Carcinoma

Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival

FAIR Checklist

Authors (7)

Funding (5 grants)

Open Access

Topics

Annotations (Europe PMC)